glp-1 receptor agonist contraindications Fixed-Ratio Combination of Basal Insulin and Glucagon-like peptide-1 receptor: mechanisms

glp-1 receptor agonist contraindications Fixed-Ratio Combination of Basal Insulin and Glucagon-like peptide-1 receptor: mechanisms

Glucagon-like peptide-1 receptor: mechanisms and advances in therapy | Signal Transduction and Targeted Therapy

10 Recently, several clinical trials have shown the potential effects of these medications in not only in glycemic control but also in the improvement of cardiovascular outcomes, weight loss, osteoarthritis, 11 metabolic dysfunction–associated steatohepatitis (MASH), 12 Parkinson’s disease, 13 chronic kidney disease (CKD) 14 and obstructive sleep apnea

As the majority of L-cells are located in the distal ileum and colon, the early phase is likely explained by neural signalling, gut peptides or neurotransmitters